Human papillomavirus (HPV), primarily transmitted through sexual contact, is responsible for nearly 37,800 cancer cases each year in the United States, including cervical, throat, and anal cancers. While most HPV infections resolve without intervention, certain strains can lead to cancer if left untreated.
The CDC’s findings add weight to the growing body of evidence supporting the importance of HPV vaccination, particularly in reducing the risk of cervical cancer, a leading cause of cancer-related deaths in women globally.
Health experts strongly advocate for HPV vaccination in both young males and females, citing its potential to prevent up to 90% of cervical cancers. Despite this, many adolescents remain unvaccinated.
Recent CDC data shows that only 76.8% of adolescents have received at least one dose of the HPV vaccine, and just 61.4% are up to date with their shots. This gap in vaccination rates underscores the need for continued awareness and action.
Electra Paskett, PhD, a prominent epidemiologist at The Ohio State University, emphasizes the importance of addressing misconceptions about HPV. “There is still a lack of awareness about HPV as a long-term cancer risk factor,” Paskett stated. “The vaccine is a critical tool in reducing this risk, and yet many people remain uninformed about how it’s transmitted and how it can be prevented.”
HPV is not only a concern for women. Men are also at risk, as HPV is linked to cancers of the throat, base of the tongue, and penis. Contrary to popular belief, the virus affects both genders and can be spread through sexual contact.
“It takes two to spread the disease,” Paskett added. “While women can be tested for HPV through routine screenings, men do not have the same testing options. This makes it even more important for everyone to get vaccinated.”
The vaccine is most effective when given prior to any exposure to the virus, typically recommended for young people between the ages of 11 and 12, though it’s still beneficial for older adolescents and young adults up to age 26. Some adults up to age 45 may also be eligible for the vaccine, depending on their vaccination history.
Zess about the vaccine and the long-term cancer risks associated with HPV. “This is a preventable cancer, and the vaccine is an incredibly powerful tool,” she said. “We’re seeing the real impact of vaccination through scientific data, and we can continue to reduce cancer rates through greater adoption of this vaccine.”
Read more:
- RFK Jr. Highlights Vitamin A And Cod Liver Oil Amid Growing Measles Outbreak
- Simple Throat Swab Could Unlock Health Insights For Older Adults
- How To Protect Yourself From Measles Amid Growing Concerns
